||Collect scientific data necessary to establish the effectiveness AND safety of BENZOAK® as an anesthetic/sedative in a variety of fish species under a variety of environmental conditions.
||BENZOAK® (20% benzocaine)
|Source of drug:
Frontier Scientific, Inc.
195 South 700 West, P.O. Box 31
Logan, Utah 84323-0031 USA
Contact: Shelley Tiev or Holly Seamons
||Immersion; standing bath treatment only
10 – 100 mg benzocaine per L
Note: For sedation to handleable, a treatment dosage of 30-40 mg benzocaine per L is recommended for all species.
Treatment duration is up to 15 minutes. Treatment duration will vary dependent upon species, water temperature, and level of sedation desired.
BENZOAK® should be applied as a single treatment event.
No withdrawal period is required for fish that are not susceptible to legal harvest for a period of 72 hours post-treatment. Fish euthanized with Benzoak® must not be sent to slaughter or be otherwise available for food until the withdrawal period has been observed.
||Investigator must collect data documenting: 1) time to sedation; and 2) time to recovery from sedation. Investigator must also report general fish behavior and any adverse effects relating to treatment.
or restrictions on use:
Investigator must follow all instructions in the Study Protocol for INAD 11-740 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.
Drug discharge must be in compliance with local NPDES permitting requirements.
contact for other information:
Bonnie Johnson, FWS - AADAP
||Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.